Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumoptik is a private medical device company developing light-based precision guidance systems to improve needle placement during epidural and related procedures. Its lead product, the BrightPoint epidural needle guidance system, is designed to provide clinicians with real-time visual feedback on tissue at the needle tip during standard loss-of-resistance epidural workflows. The company positions BrightPoint as a low-cost, easy-to-use adjunct for childbirth epidurals, spine and pain procedures, and selected orthopedic applications. Lumoptik has also described broader platform potential beyond epidurals, including orthopedic and neurology uses, and has collaborated with Hospital for Special Surgery to evaluate and expand the technology. Overall, Lumoptik appears to be an active early-stage healthcare device company rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumoptik.